S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
Log in
ASX:OBJ

Wellfully Limited (OBJ.AX) Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Wellfully Limited (OBJ.AX) (ASX:OBJ) Vs. BUX, IME, BD1, CRL, CTE, and DVL

Should you be buying OBJ stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Wellfully Limited (OBJ.AX), including (BUX) (BUX), 12144 (IME), BARD1 Life Sciences (BD1), Charles River Laboratories International (CRL), Cryosite (CTE), and dorsaVi (DVL).

(BUX) (CNSX:BUX) and Wellfully Limited (OBJ.AX) (ASX:OBJ) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Analyst Recommendations

This is a summary of current recommendations and price targets for (BUX) and Wellfully Limited (OBJ.AX), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(BUX)0000N/A
Wellfully Limited (OBJ.AX)0000N/A

Earnings & Valuation

This table compares (BUX) and Wellfully Limited (OBJ.AX)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(BUX)N/AN/AN/AN/AN/A
Wellfully Limited (OBJ.AX)$1.48 million0.00$-5,859,480.32A($0.04)N/A

(BUX) has higher earnings, but lower revenue than Wellfully Limited (OBJ.AX).

Profitability

This table compares (BUX) and Wellfully Limited (OBJ.AX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(BUX)N/AN/AN/A
Wellfully Limited (OBJ.AX)N/AN/AN/A

Summary

Wellfully Limited (OBJ.AX) beats (BUX) on 1 of the 1 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) (ASX:OBJ) and 12144 (CNSX:IME) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and price targets for Wellfully Limited (OBJ.AX) and 12144, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Wellfully Limited (OBJ.AX)0000N/A
121440000N/A

Earnings and Valuation

This table compares Wellfully Limited (OBJ.AX) and 12144's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellfully Limited (OBJ.AX)$1.48 million0.00C$-5,859,480.32A($0.04)N/A
12144N/AN/AN/AN/AN/A

12144 has lower revenue, but higher earnings than Wellfully Limited (OBJ.AX).

Profitability

This table compares Wellfully Limited (OBJ.AX) and 12144's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Wellfully Limited (OBJ.AX)N/AN/AN/A
12144N/AN/AN/A

Summary

Wellfully Limited (OBJ.AX) beats 12144 on 1 of the 1 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) (ASX:OBJ) and BARD1 Life Sciences (ASX:BD1) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Earnings & Valuation

This table compares Wellfully Limited (OBJ.AX) and BARD1 Life Sciences' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellfully Limited (OBJ.AX)$1.48 million0.00$-5,859,480.32A($0.04)N/A
BARD1 Life Sciences$464,101.000.00$-5,746,881.60A($0.07)N/A

BARD1 Life Sciences has lower revenue, but higher earnings than Wellfully Limited (OBJ.AX).

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Wellfully Limited (OBJ.AX) and BARD1 Life Sciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Wellfully Limited (OBJ.AX)0000N/A
BARD1 Life Sciences0000N/A

Profitability

This table compares Wellfully Limited (OBJ.AX) and BARD1 Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Wellfully Limited (OBJ.AX)N/AN/AN/A
BARD1 Life SciencesN/AN/AN/A

Summary

Wellfully Limited (OBJ.AX) beats BARD1 Life Sciences on 2 of the 3 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) (ASX:OBJ) and Charles River Laboratories International (CNSX:CRL) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Earnings & Valuation

This table compares Wellfully Limited (OBJ.AX) and Charles River Laboratories International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellfully Limited (OBJ.AX)$1.48 million0.00$-5,859,480.32A($0.04)N/A
Charles River Laboratories InternationalN/AN/AN/AN/AN/A

Charles River Laboratories International has lower revenue, but higher earnings than Wellfully Limited (OBJ.AX).

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Wellfully Limited (OBJ.AX) and Charles River Laboratories International, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Wellfully Limited (OBJ.AX)0000N/A
Charles River Laboratories International0000N/A

Profitability

This table compares Wellfully Limited (OBJ.AX) and Charles River Laboratories International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Wellfully Limited (OBJ.AX)N/AN/AN/A
Charles River Laboratories InternationalN/AN/AN/A

Summary

Wellfully Limited (OBJ.AX) beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) (ASX:OBJ) and Cryosite (ASX:CTE) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Profitability

This table compares Wellfully Limited (OBJ.AX) and Cryosite's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Wellfully Limited (OBJ.AX)N/AN/AN/A
CryositeN/AN/AN/A

Valuation & Earnings

This table compares Wellfully Limited (OBJ.AX) and Cryosite's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellfully Limited (OBJ.AX)$1.48 million0.00$-5,859,480.32A($0.04)N/A
Cryosite$8.97 million0.00$1.41 millionA$0.03N/A

Cryosite has higher revenue and earnings than Wellfully Limited (OBJ.AX).

Analyst Ratings

This is a breakdown of recent recommendations for Wellfully Limited (OBJ.AX) and Cryosite, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Wellfully Limited (OBJ.AX)0000N/A
Cryosite0000N/A

Summary

Cryosite beats Wellfully Limited (OBJ.AX) on 3 of the 3 factors compared between the two stocks.

dorsaVi (ASX:DVL) and Wellfully Limited (OBJ.AX) (ASX:OBJ) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations and price targets for dorsaVi and Wellfully Limited (OBJ.AX), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
dorsaVi0000N/A
Wellfully Limited (OBJ.AX)0000N/A

Profitability

This table compares dorsaVi and Wellfully Limited (OBJ.AX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
dorsaViN/AN/AN/A
Wellfully Limited (OBJ.AX)N/AN/AN/A

Earnings & Valuation

This table compares dorsaVi and Wellfully Limited (OBJ.AX)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
dorsaVi$2.02 million0.00$-12,244,714.72A($0.04)N/A
Wellfully Limited (OBJ.AX)$1.48 million0.00$-5,859,480.32A($0.04)N/A

Wellfully Limited (OBJ.AX) has lower revenue, but higher earnings than dorsaVi.

Summary

dorsaVi beats Wellfully Limited (OBJ.AX) on 2 of the 3 factors compared between the two stocks.


Wellfully Limited (OBJ.AX) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BUX
(BUX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
IME
12144
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
BD1
BARD1 Life Sciences
0.8N/AN/A$0.00$464,101.000.00High Trading Volume
Gap Up
CRL
Charles River Laboratories International
0.5N/AN/A$0.00N/A0.00Gap Up
CTE
Cryosite
0.6N/AN/A$0.00$8.97 million0.00High Trading Volume
Gap Up
DVL
dorsaVi
0.5N/AN/A$0.00$2.02 million0.00High Trading Volume
Gap Up
EPGNY
Epigenomics
0.6$14.15flat$0.00N/A0.00Gap Up
ETAH
Eternity Healthcare
0.6$0.00flat$0.00N/A0.00
GSS
Genetic Signatures
0.0N/AN/A$0.00$13.90 million0.00High Trading Volume
GTG
Genetic Technologies
0.0N/AN/A$0.00$9,864.000.00High Trading Volume
IBX
Imagion Biosystems
0.6N/AN/A$0.00$2.44 million0.00High Trading Volume
Gap Up
IDX
Integral Diagnostics
0.8N/AN/A$0.00$275.57 million0.00Dividend Announcement
High Trading Volume
Gap Up
LSH
Lifespot Health
0.5N/AN/A$0.00$43,975.000.00High Trading Volume
Gap Up
MEDD
Medical Imaging
0.4$0.01flat$0.00N/A0.00Gap Down
OSL
OncoSil Medical
0.5N/AN/A$0.00$2.76 million0.00High Trading Volume
Gap Up
PRLX
Parallax Health Sciences
0.5$0.01flat$0.00N/A0.00
RHY
Rhythm Biosciences
0.0N/AN/A$0.00$100,000.000.00High Trading Volume
Sartorius Aktiengesellschaft logo
SRT3
Sartorius Aktiengesellschaft
0.6$431.00flat$0.00N/A0.00High Trading Volume
SMMNY
Siemens Healthineers
0.4$27.81flat$0.00N/A0.00Analyst Report
SIL
Smiles Inclusive
0.4N/AN/A$0.00$36.48 million0.00High Trading Volume
Gap Up
VHT
Volpara Health Technologies Limited (VHT.AX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
WUXIF
WuXi AppTec
1.0$14.80flat$0.00N/A0.00
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.